Royal Bank of Canada Reiterates Outperform Rating for Sotera Health (NASDAQ:SHC)

Royal Bank of Canada restated their outperform rating on shares of Sotera Health (NASDAQ:SHC) in a research report released on Thursday,Benzinga reports. Royal Bank of Canada currently has a $17.00 price target on the stock.

Other equities analysts have also recently issued reports about the company. Barclays lifted their price objective on Sotera Health from $14.00 to $17.00 and gave the stock an “overweight” rating in a report on Tuesday, August 6th. Citigroup boosted their target price on shares of Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a report on Wednesday, November 6th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $16.50.

Sotera Health Price Performance

Shares of NASDAQ SHC opened at $12.82 on Thursday. Sotera Health has a twelve month low of $10.71 and a twelve month high of $17.44. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. The stock has a market cap of $3.63 billion, a P/E ratio of 51.28 and a beta of 2.08. The stock has a 50 day moving average of $15.61 and a two-hundred day moving average of $13.98.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings data on Tuesday, November 5th. The company reported $0.17 earnings per share for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.01). Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The firm had revenue of $285.47 million during the quarter, compared to analysts’ expectations of $278.64 million. During the same quarter last year, the business earned $0.18 earnings per share. The business’s quarterly revenue was up 8.5% on a year-over-year basis. On average, research analysts forecast that Sotera Health will post 0.61 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the completion of the transaction, the director now directly owns 49,215,301 shares in the company, valued at approximately $739,705,974.03. This represents a 16.89 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 55.12% of the stock is currently owned by insiders.

Institutional Trading of Sotera Health

A number of hedge funds and other institutional investors have recently made changes to their positions in SHC. CWM LLC increased its holdings in Sotera Health by 86.1% in the second quarter. CWM LLC now owns 2,146 shares of the company’s stock valued at $25,000 after buying an additional 993 shares during the last quarter. True Wealth Design LLC bought a new stake in shares of Sotera Health in the 3rd quarter valued at approximately $32,000. GAMMA Investing LLC raised its position in shares of Sotera Health by 125.0% during the 3rd quarter. GAMMA Investing LLC now owns 2,988 shares of the company’s stock valued at $50,000 after acquiring an additional 1,660 shares in the last quarter. Point72 DIFC Ltd lifted its stake in Sotera Health by 556.6% during the second quarter. Point72 DIFC Ltd now owns 6,540 shares of the company’s stock worth $78,000 after purchasing an additional 5,544 shares during the last quarter. Finally, Capital Performance Advisors LLP acquired a new position in Sotera Health in the third quarter worth $91,000. Institutional investors own 91.03% of the company’s stock.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.